Free Trial

Intelligent Bio Solutions (INBS) Competitors

Intelligent Bio Solutions logo
$1.83 +0.13 (+7.65%)
Closing price 03:59 PM Eastern
Extended Trading
$1.84 +0.01 (+0.82%)
As of 07:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

INBS vs. ECOR, POCI, NEPH, TMDIF, COCH, DRIO, PYPD, NMTC, BDMD, and LYRA

Should you be buying Intelligent Bio Solutions stock or one of its competitors? The main competitors of Intelligent Bio Solutions include electroCore (ECOR), Precision Optics (POCI), Nephros (NEPH), Titan Medical (TMDIF), Envoy Medical (COCH), DarioHealth (DRIO), PolyPid (PYPD), NeuroOne Medical Technologies (NMTC), Baird Medical Investment (BDMD), and Lyra Therapeutics (LYRA). These companies are all part of the "medical equipment" industry.

Intelligent Bio Solutions vs.

electroCore (NASDAQ:ECOR) and Intelligent Bio Solutions (NASDAQ:INBS) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, community ranking, dividends, institutional ownership, media sentiment, valuation and risk.

In the previous week, electroCore and electroCore both had 2 articles in the media. Intelligent Bio Solutions' average media sentiment score of 0.00 beat electroCore's score of -1.00 indicating that Intelligent Bio Solutions is being referred to more favorably in the news media.

Company Overall Sentiment
electroCore Negative
Intelligent Bio Solutions Neutral

electroCore has a net margin of -54.40% compared to Intelligent Bio Solutions' net margin of -323.79%. Intelligent Bio Solutions' return on equity of -146.03% beat electroCore's return on equity.

Company Net Margins Return on Equity Return on Assets
electroCore-54.40% -154.45% -69.16%
Intelligent Bio Solutions -323.79%-146.03%-83.62%

Intelligent Bio Solutions has lower revenue, but higher earnings than electroCore.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
electroCore$26.46M1.61-$18.83M-$1.56-3.69
Intelligent Bio Solutions$2.94M4.31-$10.16MN/AN/A

electroCore currently has a consensus target price of $25.50, indicating a potential upside of 343.48%. Given electroCore's stronger consensus rating and higher probable upside, research analysts plainly believe electroCore is more favorable than Intelligent Bio Solutions.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
electroCore
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
Intelligent Bio Solutions
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

electroCore has a beta of 0.79, indicating that its stock price is 21% less volatile than the S&P 500. Comparatively, Intelligent Bio Solutions has a beta of 4.58, indicating that its stock price is 358% more volatile than the S&P 500.

26.7% of electroCore shares are owned by institutional investors. Comparatively, 33.0% of Intelligent Bio Solutions shares are owned by institutional investors. 19.7% of electroCore shares are owned by insiders. Comparatively, 1.5% of Intelligent Bio Solutions shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

electroCore received 167 more outperform votes than Intelligent Bio Solutions when rated by MarketBeat users. Likewise, 62.55% of users gave electroCore an outperform vote while only 0.00% of users gave Intelligent Bio Solutions an outperform vote.

CompanyUnderperformOutperform
electroCoreOutperform Votes
167
62.55%
Underperform Votes
100
37.45%
Intelligent Bio SolutionsOutperform Votes
No Votes
Underperform Votes
1
100.00%

Summary

electroCore beats Intelligent Bio Solutions on 9 of the 15 factors compared between the two stocks.

Get Intelligent Bio Solutions News Delivered to You Automatically

Sign up to receive the latest news and ratings for INBS and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

INBS vs. The Competition

MetricIntelligent Bio SolutionsSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$12.65M$4.39B$5.57B$8.67B
Dividend YieldN/A42.68%5.27%4.19%
P/E RatioN/A28.2027.2020.16
Price / Sales4.3170.64412.92162.04
Price / CashN/A51.0838.2534.64
Price / Book2.295.967.114.72
Net Income-$10.16M$67.01M$3.23B$247.80M
7 Day Performance14.38%2.64%4.61%3.36%
1 Month Performance51.24%18.46%13.35%9.71%
1 Year Performance-1.61%18.42%31.75%14.41%

Intelligent Bio Solutions Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
INBS
Intelligent Bio Solutions
0.1096 of 5 stars
$1.83
+7.6%
N/A-12.8%$12.65M$2.94M0.0010Positive News
ECOR
electroCore
2.3693 of 5 stars
$5.01
+0.2%
$25.50
+409.0%
-14.8%$37.10M$26.46M-2.7450
POCI
Precision Optics
0.1187 of 5 stars
$4.66
+7.8%
N/A-25.5%$35.69M$17.63M-7.2780
NEPH
Nephros
2.411 of 5 stars
$3.13
+15.1%
$5.00
+59.7%
+77.2%$33.18M$15.52M-34.7830High Trading Volume
TMDIF
Titan Medical
N/A$0.29
-0.2%
N/A+511.0%$32.73M$17.63M-0.2350Gap Up
COCH
Envoy Medical
3.3762 of 5 stars
$1.50
-1.4%
$9.25
+516.7%
-37.9%$31.99M$212,000.00-1.0934News Coverage
Positive News
Gap Up
DRIO
DarioHealth
1.6202 of 5 stars
$0.70
-2.1%
$2.00
+185.7%
-45.0%$31.13M$28.03M-0.74200
PYPD
PolyPid
2.576 of 5 stars
$2.95
+5.4%
$11.33
+284.2%
-22.9%$30.06MN/A-0.5980News Coverage
Analyst Forecast
Analyst Revision
Gap Down
High Trading Volume
NMTC
NeuroOne Medical Technologies
2.118 of 5 stars
$0.59
-3.0%
$1.45
+144.6%
-29.0%$29.54M$5.76M-2.2820High Trading Volume
BDMD
Baird Medical Investment
N/A$4.41
+14.5%
N/AN/A$29.04M$37.04M0.00N/A
LYRA
Lyra Therapeutics
2.7719 of 5 stars
$20.25
+310.8%
$100.00
+393.8%
+15.0%$26.83M$1.19M-13.5950Gap Down
High Trading Volume

Related Companies and Tools


This page (NASDAQ:INBS) was last updated on 6/10/2025 by MarketBeat.com Staff
From Our Partners